The University of Kansas Cancer Center is poised to be part of a deal called “Name, Image and Likeness” that will benefit cancer research and engage KU basketball student-athletes.
KU Cancer Center has launched an investigator-initiated trial designed to attack three different targets on cancer cells at once. “The Triple Threat” approach is designed to boost CAR T-cell therapy’s chances of destroying blood cancers.
